A variety of Fusarium fungi produce a number of different mycotoxins of the class of trichothecenes and some other mycotoxins (zearalenone and fumonisins). Fusarium fungi are commonly found on cereals grown in the temperate regions of America, Europe, and Asia. There are more than 60 known trichothecene mycotoxins, one of which is nivalenol. Trichothecene mycotoxins are extremely toxic to rapidly dividing cells, including leukocytes, and one of the leading symptoms of trichothecene toxicosis is the leukopenia known as alimentary toxic aleukia 1) . We reported Vol. 59 (2) 
previously that nivalenol hinders cell proliferation 2) and induces apoptosis 3) and interleukin (IL) -8 secretion 2) in the human promyelocytic leukemia cell line HL60. In addition, intracellular calcium ion plays an important role in the exertion of nivalenol-associated toxicity 2, 3) .
Recently, mitogen-activated protein (MAP) kinases have drawn the attention of scientists, because they are important signal-transducing enzymes that are involved in numerous facets of cellular regulation, such as cell proliferation and differentiation, apoptosis, inflammation, and cytokine secretion 4, 5) . In mammals, four groups of MAP kinases --extracellular signal-regulated kinases (ERK1 and 2), c-Jun N-terminal kinases (JNK1, 2, and 3), p38 proteins (p38 , and ), and ERK5 --have been identified 4, 5) . Two of these groups (JNKs and p38s) are categorized as stress-activated MAP kinases (SAPKs). In response to external stressors, including UV light, toxic agents, and inflammatory cytokines, SAPKs are converted into their active, phosphorylated forms through kinase cascades and mediate numerous biological phenomena. In this study, to elucidate the molecular mechanism underlying the toxicity of nivalenol, we investigated the involvement of SAPKs in nivalenol-caused cytotoxicity and IL-8 secretion in HL60 cells.
Materials and Methods

Chemicals and cells
Nivalenol and SB203580 6) were purchased from Sigma-Aldrich (St. Louis, MO, USA). 
Cell proliferation
Cell proliferation was measured by 5-bromo-2-deoxyuridine (BrdU) incorporation during DNA synthesis, as described previously 8) . HL60 cells (1 10 4 cells) in 100 µL of medium containing chemical(s) were placed in each well of a 96-well microtiter plate for BrdU incorporation, and proliferation was examined after 24 h of culture.
Determination of IL-8 levels
Approximately 1 . Collected media were centrifuged at 5,000 g for 5 min to remove cells and cell debris, and the supernatants were assayed. Levels of IL-8 were quantified with a Quantikine
Human IL-8 Immunoassay kit (R&D Systems, Inc., Minneapolis, MN, USA) in accordance with the manufacturer's recommended procedure.
Statistics
Data were expressed as means ± standard deviation. Differences between groups were analyzed by Tukey's test. A P value of < 0.05 was considered to indicate significance.
Results
We quantified phosphorylated SAPKs after 24 h of treatment with nivalenol at various concentrations, because the phosphorylated forms are known to be active forms 4, 5) . Vehicle-treated HL60 cells contained little phosphorylated JNKs (Fig. 1A) . Nivalenol increased the quantity of active forms; the quantity peaked at a nivalenol concentration of around 1 µg/mL (Fig. 1A) . Essentially the same trend was observed with phosphorylated p38s (Fig. 1B) .
The amounts of phosphorylated SAPKs were peaked at around 1 µg/mL (Fig. 1) , we therefore used this concentration in our time-course experiments. Exposure to nivalenol increased phosphorylated JNK levels in HL60 cells with time until 12 h, after which the levels decreased (Fig.   2A) ; at 24 h, phosphorylated JNKs were less abundant than at 6 h. The phosphorylated p38 assessment gave almost the same results as for phosphorylated JNKs as a function of time (Fig. 2B ).
These results led us to hypothesize that nivalenol exerts its toxicity through SAPK signaltransduction pathways. To elucidate the functions of SAPKs, we investigated the effects of specific SAPK inhibitors on nivalenol-caused cytotoxicity and IL-8 secretion.
We investigated the effects of the JNK-specific inhibitor SP600125 7) and the p38-specific inhibitor SB203580 6) on cell proliferation. In our hands, cell proliferation was the most sensitive measure of cell viability, and the 50 % inhibitory concentration was about 0.16 µg/mL 2)
, therefore, we performed these experiments at a concentration of nivalenol of 0.3 µg/mL. We chose the lowest effectual concentrations of 20 and 5 µmol/L as the final concentrations of SP600125 and SB203580, respectively. As reported previously 2)
As shown in Table 2 , nivalenol elicited IL-8 secretion in HL60 cells. This is consistent with our previous result 2)
. SP600125 significantly reduced nivalenol-induced IL-8 secretion (Table 2 ). Since the effect of SP600125 alone was trivial (92.2 % of the value for IL-8 secretion in vehicle-treated samples; Table 2 ), JNKs appear important for nivalenol-induced IL-8 secretion. SB203580 lessened nivalenol-induced IL-8 secretion (Table 2) . Although this effect was not very substantial, taking the marked increase in IL-8 secretion induced by SB203580 alone (1,027.5 %; Table 2 ) into consideration, it is conceivable that p38s contribute to nivalenol-induced IL-8 secretion.
Discussion
To our knowledge, no one had demonstrated the involvement of SAPKs in nivalenol toxicity, although the involvement of SAPKs in the signal transduction pathway associated with the toxicity of deoxynivalenol, another trichothecene mycotoxin, has been reported 9-11) . Here, we showed the importance of these enzymes in the exertion of nivalenol toxicity in HL60 cells.
According to Pestka et al., . Although nivalenol and deoxynivalenol are structurally very much alike, these results indicate that nivalenol toxicity is different from deoxynivalenol toxicity.
Moon and Pestka 13) and Zhou et al. 14) reported that deoxynivalenol immediately stimulated phosphorylated SAPKs within 15 min; the stimulation then tapered off, and no SAPKs were detected at the end of 8 h of treatment in murine macrophage RAW 264.7 cells. The difference in the time course of phosphorylated SAPK production between nivalenol (Fig. 2 ) and deoxynivalenol 13, 14) might account for the difference in the toxicities of these two compounds.
The amounts of phosphorylated SAPKs produced with 3 µg/mL nivalenol were smaller than those at 1 and 0.3 µg/mL (Fig. 1) . This phenomenon can be accounted for by cell damage, because nivalenol at 3 µg/mL or higher induces apoptosis in HL60 cells 3) , and morphologic damage is also apparent at this concentration 2)
.
As reported by Hobbie et al. 15) , Oltmanns et al. 16) , and Nagashima et al. 17) , it is common that SAPKs contribute to IL-8 secretion. Islam et al. reported that deoxynivalenol-elicited IL-8 secretion is p38-dependent but not JNK-dependent in human U937 monocyte cells and human primary blood mononuclear cells 11) . The discrepancy between their results and ours ( 
